ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Feb 27, 2017
Insider Transaction Report
Form 4
Ward Carter Julian
Chief Financial Officer
Transactions
- Award
Common Stock
2017-02-23$0.23/sh+133,019$29,996→ 1,885,304 total
Holdings
- 1,355,014(indirect: By IRA)
Common Stock